In focus · trending topic

Biothera Pharmaceuticals

2 stories · following the connections

Biothera Pharmaceuticals’ Phase 2 Study of Imprime PGG Combination Therapy in Non-Small Cell Lung Cancer Patients Published in Investigational New Drugs

By Nasdaq OMXMar 24, 2017, 2:00 PM UTC

Biothera Pharmaceuticals Announces Presentation of Clinical Data Supporting Use of a Patient Selection Biomarker for its Phase 2 Cancer Immunotherapy

By Nasdaq OMXFeb 24, 2017, 7:24 PM UTC